4 reports

  • Stage Of Development
  • BIOMARKER BASED DIAGNOSTIC ASSAY - CARDIAC DISEASE - PRODUCT DESCRIPTION

UCD offers inter-institutional collaborative programs and research centers in the areas which include sensor web technologies, systems biology and nanobiotechnology and biopharmaceuticals, among others.

  • Chronic Disease
  • Healthcare
  • Surgery
  • United States
  • Pfizer Inc.
  • Type1 diabetes (Juvenile Diabetes) - Companies Involved in Therapeutics Development

ORAL HDV-INSULIN USES A UNIQUE, BIONANOTECHNOLOGY BASED CELL TARGETING SYSTEM TO PREFERENTIALLY DELIVER INSULIN TO SPECIFIC SITES IN THE BODY.

  • Chronic Disease
  • Surgery
  • United States
  • Company
  • Product Initiative
  • 3.7 PATENT TRENDS

New area of research called nanobiotechnology has also emerged.

  • Chronic Disease
  • Surgery
  • World
  • Market Size
  • DePuy Synthes, Inc.
  • UNIVERSITY COLLEGE DUBLIN PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • Cardiac Markers Tests Companies and Product Overview

Consolidated net profit : € ## ##. ## million, equal to ## ##. ## % of revenues, + ##. ##% compared to € ## ##. ## million in 2013.

  • Cardiovascular Disease
  • Chronic Disease
  • Clinical Trial
  • Surgery
  • Company